Although metabolic syndrome (MS) is associated with adverse cardiovascular outcomes, its association with presence and extent of coronary atherosclerotic plaques is not well described. To assess this relationship, multi-detector computed tomography (MDCT) based pattern of coronary plaques were assessed in 77 patients enrolled in the ROMICAT study (age 54±12 years, 79% Caucasians and 36% females) and compared among those who did (n=35, 45%) and did not (n=42, 55%) have MS. The presence of any, calcified, and non-calcified plaque was significantly higher in patients with than without MS (91%, 74%, and 77% vs. 46%, 45%, and 40% segments with plaque respectively, all p<0.01). The overall number of segments with plaques was also higher in MS patients (5.8±3.7 vs. 2.1±3.3, p<0.001). Metabolic syndrome was independently associated with both presence and extent of overall plaques after adjusting for the Framingham risk score (OR 6.7, p<0.01 for presence, β coefficient 3.59, SE 0.88, p=0.009 for extent) and for individual risk factors including age, gender, smoking, body mass index, hypertension, diabetes, hyperlipidemia, and clinical coronary disease (OR 8.4, p=0.008 for presence, β coefficient 2.35, SE 0.86, p=0.007 for extent). Similarly, MS was independently associated with calcified and non-calcified plaques individually. In conclusion, MS is independently associated with the presence and extent of both calcified and non-calcified coronary atherosclerotic plaques as detected by MDCT. These data may explain the higher cardiovascular risk in these patients and may lay the foundation for studies to determine whether such information may improve risk stratification.
Keywords
Conflict of Interest: NonePublisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain. Metabolic syndrome (MS) is associated with an increased risk of adverse cardiovascular events and mortality. (1-3) It is highly prevalent in the United States adult population. (4) Recently the American Heart Association and the National Heart Lung and Blood Institute issued a joined statement on MS providing the revised diagnostic criteria. (5) The exact mechanism by which MS exerts excess risk is under active investigation. Accelerated coronary atherosclerosis may be related to the excess clinical risk associated with MS, as sub-clinical atherosclerosis is associated with increased adverse event rate. (6-7) Although some studies suggest increased coronary calcification in patients with MS, others did not find an association between MS and angiographic coronary disease. (8-10) The overall presence, type and extent of atheroscl...